Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2018 Feb 19;120(4):401–408. doi: 10.1016/j.anai.2018.02.013

Table 3.

Asthma Outcomes at baseline, 3 months (end of the intervention) and 6 months.

Baseline
3 months
6 months
Outcomes N Usual
Care
(n=183)
Intervention
(n=180)
N Usual
Care
(n=143)
Intervention
(n=136)
p1 N Usual
Care
(n=87)
Intervention
(n=100)
p2
Symptom free days 363 7.4 (5.3) 7.2 (5.3) 279 8.4 (5.3) 8.0 (5.6) 0.51 186 9.4 (5.1) 8.8 (5.1) 0.55
Asthma knowledge 361 15.4 (2.8) 15.2 (2.3) -- -- -- -- 184 15.3 (2.5) 15.3 (2.3) 0.62
CHSA physical health 361 78.1 (15.9) 74.3 (16.7) 277 79.7 (16.6) 81.6 (15.8) 0.16 185 83.6 (14.5) 77.5 (17.3) 0.19
CHSA activity child 356 83.7 (16.9) 80.9 (17.9) 275 85.5 (15.7) 85.2 (17.5) 0.61 179 86.6 (14.6) 83.8 (18.5) 0.83
CHSA activity family 362 91.5 (12.8) 89.8 (11.5) -- -- -- -- 186 94.6 (8.7) 89.2 (14.4) 0.02
CHSA emotion health child 363 76.2 (25) 73.9 (25.9) 279 80.1 (23.6) 80.1 (23.8) 0.46 186 81.7 (23.5) 74.4 (25.2) 0.31
CHSA emotion health family 362 77.3 (13.2) 77.3 (13) -- -- -- -- 185 81.9 (11.3) 78.2 (12) 0.12
Peak flow meter use (yes) 363 60 (33%) 45 (25%) 278 51 (36%) 104 (76%) <0.01 187 39 (45%) 79 (79%) <0.01
Takes medication as prescribed all of the time or almost all of the time 363 133 (73%) 124 (69%) 279 107 (75%) 97 (71%) 0.77 187 55 (63%) 78 (78%) 0.03
Child self-efficacy, mean (SD) 309 50.3 (9.7) 49 (10.4) -- -- -- -- 145 51.8 (9.1) 52.1 (11.0) 0.66
Caregiver self-efficacy (SD) 357 46 (5.4) 46 (5.4) -- -- -- -- 186 46.9 (5.4) 47.2 (5) 0.38
Asthma control 360 273 184 0.37
  Well controlled 40 (22%) 39 (22%) 28 (20%) 31 (23%) 0.33 15 (18%) 19 (19%)
  Not well controlled 40 (22%) 36 (20%) 33 (24%) 28 (21%) 25 (30%) 22 (22%)
  Very poorly controlled 100 (56%) 105 (58%) 77 (56%) 76 (56%) 44 (52%) 59 (59%)